This report contains market size and forecasts of Tenofovir Alafenamide and Its Combination Drugs in Global, including the following market information:
Global Tenofovir Alafenamide and Its Combination Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tenofovir Alafenamide and Its Combination Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tenofovir Alafenamide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tenofovir Alafenamide and Its Combination Drugs include Affine Formulations Limited, Beacon Pharmaceuticals, Biocon Limited, Cipla, Flamingo Pharmaceuticals Limited, Gilead Sciences, IPCA Laboratories, Johnson and Johnson and Julphar Bangladesh, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tenofovir Alafenamide and Its Combination Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tenofovir Alafenamide and Its Combination Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tenofovir Alafenamide and Its Combination Drugs Market Segment Percentages, by Type, 2021 (%)
Tenofovir Alafenamide
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide
Emtricitabine/Rilpivirine/Tenofovir Alafenamide
Emtricitabine/Renofovir Alafenamide
Bictegravir/Emtricitabine/Tenofovir Alafenamide
Global Tenofovir Alafenamide and Its Combination Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tenofovir Alafenamide and Its Combination Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Drug Center
Other
Global Tenofovir Alafenamide and Its Combination Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tenofovir Alafenamide and Its Combination Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tenofovir Alafenamide and Its Combination Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tenofovir Alafenamide and Its Combination Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Affine Formulations Limited
Beacon Pharmaceuticals
Biocon Limited
Cipla
Flamingo Pharmaceuticals Limited
Gilead Sciences
IPCA Laboratories
Johnson and Johnson
Julphar Bangladesh
Medisist Pharma
Mylan Pharmaceuticals
Natco Pharma
Sun Pharmaceutical Industries
CHIA TAI TIANQING (CTTQ) Pharmaceutical